{
    "N/R/U": null,
    "Applicant": "Biocon Biologics Inc.",
    "BLA Number": "761274",
    "Proprietary Name": "Yesafili",
    "Proper Name": "aflibercept-jbvf",
    "BLA Type": "351(k) Interchangeable",
    "Strength": "2MG/0.05ML",
    "Dosage Form": "Injection ",
    "Route of Administration": "Intravitreal",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "20-May-24",
    "Ref. Product Proper Name": "aflibercept",
    "Ref. Product Proprietary Name": "Eylea",
    "Supplement Number": null,
    "Submission Type": "Original",
    "License Number": "2324",
    "Product Number": "1",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": "Date TBD",
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}